PUREfrex® is a CosmoBio in in vitro coupled transcription/translation system, based on E. coli translation machinery.

By adding DNA or mRNA that encodes the target protein to the reaction solution, proteins can be synthesized easily and quickly without using living cells.

Purification with an advanced protocol, allow to obtain protein integrity and functionality.

 

 

Advantages for research processes:

Advantages for protein expression processes:

 

PUREfrex® Version Comparison

Version 1.0 2.0/2.1

Yield of synthesized E. coli dihydrofolate
reductase (DHFR)

150 ug/ml

600 ug/ml

Reaction volume required for 100ug DHFR

660 ul (> 3 kits)

160 ul (< 1 kit)

Yield of synthesized GFP

100 ug/ml

800 ug/ml

Reaction volume required for 100ug GFP

1000 ul (> 4 kits)

125 ul (< 1 kit)

Protein Preparation

--

++

Protein Science (translation, protein folding, etc.)

++

--

Synthetic Biology

++

++

 

Download Purefrex Brochure

 

Watch the registered webinar with iBody Inc, focused on "Antibody Discovery": 

Antibody Discovery Powered by PUREfrex® and iBody Inc. ?Rapid. Reliable. Remarkable. Resourceful?

 


Richiedi un'offerta

DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)
Tel. +39 02-26922300

If you no longer wish to receive these announcements click here